87 related articles for article (PubMed ID: 15918155)
1. A murine model of acute liver injury induced by human monoclonal autoantibody.
Yamauchi K; Yamaguchi N; Furukawa T; Takatsu K; Nakanishi T; Ishida K; Komatsu T; Tokushige K; Nagahara H; Hashimoto E; Shiratori K
Hepatology; 2005 Jul; 42(1):149-55. PubMed ID: 15918155
[TBL] [Abstract][Full Text] [Related]
2. A novel IgM class autoantibody to a hepatocyte-related 190 kDa molecule in patients with type 1 autoimmune hepatitis.
Yamauchi K; Yamaguchi N; Furukawa T; Takatsu K; Nakanishi T; Sasaki M; Isono E; Tokushige K; Komatsu T; Shiratori K
Hepatology; 2004 Sep; 40(3):687-92. PubMed ID: 15349908
[TBL] [Abstract][Full Text] [Related]
3. Cytotoxic effect of an anti-liver monoclonal autoantibody obtained after neonatal thymectomy in mice.
Yoshida Y; Myozaki M; Kuroda E; Yamashita U
J Autoimmun; 2001 Jun; 16(4):373-82. PubMed ID: 11437485
[TBL] [Abstract][Full Text] [Related]
4. A murine model of type 2 autoimmune hepatitis: Xenoimmunization with human antigens.
Lapierre P; Djilali-Saiah I; Vitozzi S; Alvarez F
Hepatology; 2004 Apr; 39(4):1066-74. PubMed ID: 15057911
[TBL] [Abstract][Full Text] [Related]
5. Vascular endothelial growth factor reduces Fas-mediated acute liver injury in mice.
Tanaka Y; Sohda T; Matsuo K; Anan A; Irie M; Takeyama Y; Iwata K; Shakado S; Sakisaka S
J Gastroenterol Hepatol; 2008 Jul; 23(7 Pt 2):e207-11. PubMed ID: 17784864
[TBL] [Abstract][Full Text] [Related]
6. Pathogenesis of autoimmune hepatitis: from break of tolerance to immune-mediated hepatocyte apoptosis.
Lapierre P; Béland K; Alvarez F
Transl Res; 2007 Mar; 149(3):107-13. PubMed ID: 17320796
[TBL] [Abstract][Full Text] [Related]
7. A rat model of acute liver necrosis induced by a monoclonal antibody to liver-specific antigen and complement.
Ikeda T; Kurebayashi Y
Hepatology; 1991 Jun; 13(6):1152-7. PubMed ID: 1711004
[TBL] [Abstract][Full Text] [Related]
8. Overexpression of granulocyte-macrophage colony-stimulating factor in mouse liver enhances the susceptibility of lipopolysaccharide leading to massive apoptosis of hepatocytes.
Hirano K; Shimizu Y; Nakayama Y; Minemura M; Yasumura S; Sugiyama T
Liver Int; 2005 Oct; 25(5):1027-35. PubMed ID: 16162163
[TBL] [Abstract][Full Text] [Related]
9. Complement mediated hepatocytes injury in a model of autoantibody induced hepatitis.
Tu Z; Li Q; Chou HS; Hsieh CC; Meyerson H; Peters MG; Bu H; Fung JJ; Qian S; Lu L; Lin F
Immunobiology; 2011 Apr; 216(4):528-34. PubMed ID: 20851495
[TBL] [Abstract][Full Text] [Related]
10. Autoimmune diseases of the liver and biliary tract and overlap syndromes in childhood.
Maggiore G; Riva S; Sciveres M
Minerva Gastroenterol Dietol; 2009 Mar; 55(1):53-70. PubMed ID: 19212308
[TBL] [Abstract][Full Text] [Related]
11. Elevated serum BAFF levels in patients with autoimmune hepatitis.
Migita K; Abiru S; Maeda Y; Nakamura M; Komori A; Ito M; Fujiwara S; Yano K; Yatsuhashi H; Eguchi K; Ishibashi H
Hum Immunol; 2007 Jul; 68(7):586-91. PubMed ID: 17584580
[TBL] [Abstract][Full Text] [Related]
12. c-Met confers protection against chronic liver tissue damage and fibrosis progression after bile duct ligation in mice.
Giebeler A; Boekschoten MV; Klein C; Borowiak M; Birchmeier C; Gassler N; Wasmuth HE; Müller M; Trautwein C; Streetz KL
Gastroenterology; 2009 Jul; 137(1):297-308, 308.e1-4. PubMed ID: 19208365
[TBL] [Abstract][Full Text] [Related]
13. Immunohistopathological reactions for liver-specific membrane lipo-protein in experimental autoimmune hepatitis.
Chattopadhyay D; Sen MR; Aryya NC
Indian J Pathol Microbiol; 1999 Jul; 42(3):291-7. PubMed ID: 10862286
[TBL] [Abstract][Full Text] [Related]
14. Humoral immune mechanism of liver injury in giant cell hepatitis with autoimmune hemolytic anemia.
Whitington PF; Vos MB; Bass LM; Melin-Aldana H; Romero R; Roy CC; Alvarez F
J Pediatr Gastroenterol Nutr; 2014 Jan; 58(1):74-80. PubMed ID: 23969541
[TBL] [Abstract][Full Text] [Related]
15. Upregulation of indoleamine 2,3-dioxygenase in hepatocyte during acute hepatitis caused by hepatitis B virus-specific cytotoxic T lymphocytes in vivo.
Iwamoto N; Ito H; Ando K; Ishikawa T; Hara A; Taguchi A; Saito K; Takemura M; Imawari M; Moriwaki H; Seishima M
Liver Int; 2009 Feb; 29(2):277-83. PubMed ID: 18397228
[TBL] [Abstract][Full Text] [Related]
16. Antinecrotic and antiapoptotic effects of hepatocyte growth factor on cholestatic hepatitis in a mouse model of bile-obstructive diseases.
Li Z; Mizuno S; Nakamura T
Am J Physiol Gastrointest Liver Physiol; 2007 Feb; 292(2):G639-46. PubMed ID: 17068118
[TBL] [Abstract][Full Text] [Related]
17. Autoantibodies to liver-specific lipoprotein following hepatitis induced by mouse cytomegalovirus.
Bartholomaeus WN; Shellam GR; Allan JE; Reed WD; Joske RA
Clin Exp Immunol; 1983 Apr; 52(1):89-97. PubMed ID: 6305543
[TBL] [Abstract][Full Text] [Related]
18. HCV core expression in hepatocytes protects against autoimmune liver injury and promotes liver regeneration in mice.
Kawamura H; Govindarajan S; Aswad F; Machida K; Lai MM; Sung VM; Dennert G
Hepatology; 2006 Oct; 44(4):936-44. PubMed ID: 17006910
[TBL] [Abstract][Full Text] [Related]
19. Rat hepatocyte engraftment in severe combined immunodeficient x beige mice using mouse-specific anti-fas antibody.
Wilson JH; Paturzo FX; Johnson LK; Carreiro MP; Hixson DC; Mennone A; Boyer JL; Pober JS; Harding MJ
Xenotransplantation; 2006 Jan; 13(1):53-62. PubMed ID: 16497212
[TBL] [Abstract][Full Text] [Related]
20. Fulminant liver failure triggered by therapeutic antibody treatment in a mouse model.
Matsuda Y; Toda M; Kato T; Kuribayashi K; Kakimi K
Int J Oncol; 2006 Nov; 29(5):1119-25. PubMed ID: 17016642
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
